[Pharmacokinetics of ampicillin in peritonitis in children]

Antibiotiki
|August 1, 1978
PubMed

Insights

Intravenous ampicillin infusion effectively treats appendicular peritonitis by achieving therapeutic levels in tissues. Higher doses and less severe appendicitis correlate with better antibiotic concentration.

Area of Science:

  • Pharmacology
  • Pediatric Surgery
  • Infectious Diseases

Background:

  • Appendicular peritonitis in children necessitates effective antibiotic therapy.
  • Understanding ampicillin pharmacokinetics is crucial for optimizing treatment.
  • Assessing antibiotic levels in various body fluids and tissues is key.

Observation:

  • Ampicillin was administered via intravenous jet infusion and continuous drop infusion in children with appendicular peritonitis.
  • Blood serum and abdominal cavity biosubstrate levels were measured.
  • The extent of appendix destruction (gangrenous vs. catarrhal) influenced ampicillin levels.

Findings:

  • Intravenous jet infusion achieved therapeutic ampicillin levels in appendix tissue and exudate.
  • Higher ampicillin doses resulted in increased biosubstrate levels.
  • Gangrenous appendicitis showed 1.5–2.2 times lower ampicillin levels than catarrhal appendicitis.
  • Continuous drop infusion maintained high, stable blood serum ampicillin levels above the minimum inhibitory concentration (MIC).
  • Intraperitoneal administration post-operatively yielded insignificant blood absorption.

Implications:

  • Intravenous ampicillin administration, particularly via continuous infusion, is effective for appendicular peritonitis.
  • The severity of appendicitis impacts antibiotic efficacy, suggesting dose or regimen adjustments may be needed.
  • Further research into optimal dosing strategies based on disease severity is warranted.

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...